DR. LOUIS J AVVENTO MD NPI 1417999533

NPI Information

  • NPI: 1417999533
  • Provider Name: DR. LOUIS J AVVENTO, MD
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 640 COUNTY ROAD 39
    SOUTHAMPTON, NY
    ZIP 11968
  • Phone: (631) 751-3000

Map and Directions

Get Directions

NPI Details

DR. Louis J Avvento, MD is a hematology and oncology internal medicine in Southampton, NY with 45 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Louis J Avvento, MD NPI is 1417999533. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

640 COUNTY ROAD 39
SOUTHAMPTON, NY
ZIP 11968-219
Phone: (631) 751-3000
Fax: (631) 509-6559

The NPI 1417999533 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, nivolumab, 1 mg (HCPCS:J9299)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
  • Injection, iron sucrose, 1 mg (HCPCS:J1756)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
  • Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection, rituximab-arrx, biosimilar, (riabni), 10 mg (HCPCS:Q5123)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Magnesium level (HCPCS:83735)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Uric acid level, blood (HCPCS:84550)
  • Iron binding capacity (HCPCS:83550)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
  • Phosphate level (HCPCS:84100)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Folic acid level, serum (HCPCS:82746)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Red blood count, manual test (HCPCS:85044)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Vitamin d-3 level (HCPCS:82306)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Protein measurement, serum (HCPCS:84165)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Beta-2 microglobulin (protein) level (HCPCS:82232)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Thyroxine (thyroid chemical), total (HCPCS:84436)
  • Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Testosterone (hormone) level, total (HCPCS:84403)
  • Blood test, clotting time (HCPCS:85610)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Haptoglobin (serum protein) level (HCPCS:83010)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
  • Hemoglobin a1c level (HCPCS:83036)
  • Urinalysis, manual test (HCPCS:81002)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
  • Blood test, basic group of blood chemicals (calcium, ionized) (HCPCS:80047)
  • Red blood cell concentration measurement (HCPCS:85014)
  • Influenza vaccine split virus, preservative free (HCPCS:90662)
  • Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Infusion, normal saline solution, 250 cc (HCPCS:J7050)
  • Parathormone (parathyroid hormone) level (HCPCS:83970)
  • Acute hepatitis panel (HCPCS:80074)
  • Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99426)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
  • Bilirubin level, total (HCPCS:82247)
  • Coagulation function measurement, d-dimer; quantitative (HCPCS:85379)
  • Injection, lorazepam, 2 mg (HCPCS:J2060)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody (HCPCS:86769)
  • Alpha-fetoprotein (afp) level, serum (HCPCS:82105)
  • Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) (HCPCS:G0506)
  • Phosphatase (enzyme) measurement, acid, total (HCPCS:84060)
  • Ige (immune system protein) level (HCPCS:82785)
  • Cortisol (hormone) measurement, total (HCPCS:82533)
  • Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99439)
  • Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
  • Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
  • Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
  • Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
  • Measurement c-reactive protein for detection of infection or inflammation, high sensitivity (HCPCS:86141)
  • Stool analysis for blood to screen for colon tumors (HCPCS:82270)
  • Blood glucose (sugar) level (HCPCS:82947)
  • Coagulation assessment blood test, plasma or whole blood (HCPCS:85730)
  • Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
  • Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free (HCPCS:90674)

The enumeration date for this NPI number is 6/12/2006 and was last updated on 1/30/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology161779NEW YORKYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1830007838OTHERNEW YORKRAIL ROAD MEDICARE
201104521MEDICAIDNEW YORK
314B862OTHERNEW YORKBLUE CROSS

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.